Listed by the USPTO as DUNN, LINDSAY MICHELLE
Tech Center 1600 • Art Units: 1600 1641 1642 1643 1644 1671 1681
This examiner grants 80% of resolved cases
DUNN, LINDSAY MICHELLE is a USPTO patent examiner in tech center 1600 and art unit 1600. The profile contains 5 resolved cases, an 80.0% allowance rate, and a median of 1216 days to allowance. The interview lift is 0.0%, so the available data does not show an interview-associated change in allowance outcomes.
The listed companies are Janssen Pharmaceuticals Inc., Riken, and Bms. The listed firms are FOLEY & LARDNER LLP, NOVICK, KIM & LEE, PLLC, dba NKL Law, and The Roy Gross Law Firm, LLC. Because the resolved-case record is very limited, practitioners should avoid treating the figures as a broad predictor and should focus on the specific application record.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18034621 | CHIMERIC ANTIGEN RECEPTOR (CAR)-T CELL EXPRESSING CXCL12 RECEPTOR | Final Rejection | RIKEN |
| 18365950 | CHIMERIC ANTIGEN RECEPTORS SPECIFIC FOR GPRC5D AND BCMA | Non-Final OA | Juno Therapeutics, Inc. |
| 18285205 | CITRULLINATED PROTEINS AS BIOMARKERS AND THERAPY TARGETS FOR CANCER | Non-Final OA | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM |
| 18287551 | CHIMERIC ANTIGEN RECEPTOR (CAR)-T CELLS | Non-Final OA | Imperial College Innovations Limited |
| 18554263 | DPEP-1 BINDING AGENTS AND METHODS OF USE | Non-Final OA | National Research Council of Canada |
| 18261983 | BONE-SPECIFIC DELIVERY OF POLYPEPTIDES | Final Rejection | Baylor College of Medicine |
| 18360742 | USE OF CYP4V2 AND RDCVF IN THE MANUFACTURE OF MEDICAMENT | Non-Final OA | CHIGENOVO CO., LTD. |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy80.0% of resolved applications examined by Lindsay Michelle Dunn were allowed (5 resolved cases), compared with 37.3% across Art Unit 1600 over the last five years.
This examiner's interview lift is +0.0 percentage points: the difference in allowance rate between resolved applications that had an examiner interview and those that did not.
Applications allowed by Lindsay Michelle Dunn took 1,216 days on average from filing to allowance.
Lindsay Michelle Dunn examines applications in Art Unit 1600 in Tech Center 1600 (Biotechnology & Pharmaceuticals).
